Testing effectiveness (Phase 2)Active Not RecruitingNCT03224767
What this trial is testing
Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma
Who this might be right for
BRAF V600E Mutation PresentPapillary Craniopharyngioma
Alliance for Clinical Trials in Oncology 24